April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Alterations of Angiopoietin 1 and 2 Expression in Diabetic Retinopathy
Author Affiliations & Notes
  • S. Rangasamy
    Department of Cell Biology and Physiology,
    University of New Mexico School of Med, Albuquerque, New Mexico
  • R. Srinivasan
    Department of Cell Biology and Physiology,
    University of New Mexico School of Med, Albuquerque, New Mexico
  • J. Maestas
    Department of Cell Biology and Physiology,
    University of New Mexico School of Med, Albuquerque, New Mexico
  • P. McGuire
    Department of Cell Biology and Physiology,
    University of New Mexico School of Med, Albuquerque, New Mexico
  • A. Das
    Department of Surgery/Ophthalmology,
    University of New Mexico School of Med, Albuquerque, New Mexico
    Department of Surgery, New Mexico VA Health Care System, Albuquerque, New Mexico
  • Footnotes
    Commercial Relationships  S. Rangasamy, None; R. Srinivasan, None; J. Maestas, None; P. McGuire, None; A. Das, None.
  • Footnotes
    Support  NIH Grant EY12604 and JDRF 1-2006-36
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 19. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Rangasamy, R. Srinivasan, J. Maestas, P. McGuire, A. Das; Alterations of Angiopoietin 1 and 2 Expression in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):19. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : One of the hallmarks of diabetic retinopathy is the alteration of the blood-retinal barrier resulting in macular edema. Although the VEGF has been identified as an important mediator of this process, there are other molecules which may also play a role. To study the role of angiopoietins in alteration of the blood-retinal-barrier, we examined the expression pattern of angiopoietins in an animal model of diabetic retinopathy, as well as in human retinal endothelial cells (HRECs) treated with high glucose and high glucose flux.

Methods: : Diabetes was induced in Sprague-Dawley rats by a single intraperitoneal injection of streptozotocin. HRECs were grown to confluence, and treated with high glucose (30.5 mM) for 72 hours and glucose flux (alternate cycles of 5.5mM and 30.5 mM) for a total of 72 hours. RNA was extracted from the rat retina and HRECs, and angiopoietins 1 and 2 (Ang-1 & Ang-2) levels were analyzed by quantitative RT-PCR and western blot analysis.

Results: : There is a significant increase in Ang -2 mRNA levels in retinal tissues of rats with 5 and 8 week duration of diabetes. HRECs treated with high glucose and glucose flux conditions showed a significant elevation in the levels of both Ang-1 and Ang-2. The increased levels of Ang-2 protein were also confirmed by western blot analysis in cells treated with high glucose. Interestingly, the ratio of Ang-2/Ang-1 was elevated in both HRECs and in the retinas of diabetic rats.

Conclusions: : Hyperglycemia induces the expression of both Ang-1 and Ang-2 in diabetic rat retina and isolated retinal endothelial cells. An understanding of the role of angiopoietins during the early stages of diabetic retinopathy may help us to elucidate the molecular mechanisms of blood-retinal-barrier alteration, and possibly lead to the development of novel therapeutic targets for this disease.

Keywords: diabetic retinopathy • growth factors/growth factor receptors • cell adhesions/cell junctions 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×